NCT02800928View on ClinicalTrials.gov

Does CERC-501 Attenuate Stress-precipitated Smoking Lapse?

PHASE2CompletedINTERVENTIONAL

Enrollment

17

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

January 2, 2018

Study Completion Date

January 2, 2018

Conditions

Smoking

Interventions

DRUG

CERC-501

CERC-501

DRUG

Placebo

Placebo

Trial Locations (1)

06519

Yale University School of Medicine, New Haven

Sponsors

Collaborators (1)

Janssen Pharmaceuticals

All Listed Sponsors

collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

Office of Research on Women's Health (ORWH)

NIH

collaborator

Janssen Pharmaceuticals

INDUSTRY

lead

Yale University

OTHER